Bausch and Glenmark announce approval of RYALTRIS in Canada
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
One in two women with advanced ovarian cancer has an HRD-positive tumor
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Subscribe To Our Newsletter & Stay Updated